These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 22144686)

  • 1. MeCP2 binds to nucleosome free (linker DNA) regions and to H3K9/H3K27 methylated nucleosomes in the brain.
    Thambirajah AA; Ng MK; Frehlick LJ; Li A; Serpa JJ; Petrotchenko EV; Silva-Moreno B; Missiaen KK; Borchers CH; Adam Hall J; Mackie R; Lutz F; Gowen BE; Hendzel M; Georgel PT; Ausió J
    Nucleic Acids Res; 2012 Apr; 40(7):2884-97. PubMed ID: 22144686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MeCP2 preferentially binds to methylated linker DNA in the absence of the terminal tail of histone H3 and independently of histone acetylation.
    Ishibashi T; Thambirajah AA; Ausió J
    FEBS Lett; 2008 Apr; 582(7):1157-62. PubMed ID: 18339321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state.
    Skene PJ; Illingworth RS; Webb S; Kerr AR; James KD; Turner DJ; Andrews R; Bird AP
    Mol Cell; 2010 Feb; 37(4):457-68. PubMed ID: 20188665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MeCP2 binds cooperatively to its substrate and competes with histone H1 for chromatin binding sites.
    Ghosh RP; Horowitz-Scherer RA; Nikitina T; Shlyakhtenko LS; Woodcock CL
    Mol Cell Biol; 2010 Oct; 30(19):4656-70. PubMed ID: 20679481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin.
    Hansen JC; Ghosh RP; Woodcock CL
    IUBMB Life; 2010 Oct; 62(10):732-8. PubMed ID: 21031501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MeCP2-chromatin interactions include the formation of chromatosome-like structures and are altered in mutations causing Rett syndrome.
    Nikitina T; Ghosh RP; Horowitz-Scherer RA; Hansen JC; Grigoryev SA; Woodcock CL
    J Biol Chem; 2007 Sep; 282(38):28237-45. PubMed ID: 17660293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired in vivo binding of MeCP2 to chromatin in the absence of its DNA methyl-binding domain.
    Stuss DP; Cheema M; Ng MK; Martinez de Paz A; Williamson B; Missiaen K; Cosman JD; McPhee D; Esteller M; Hendzel M; Delaney K; Ausió J
    Nucleic Acids Res; 2013 May; 41(9):4888-900. PubMed ID: 23558747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain phosphorylation of MeCP2 at serine 164 is developmentally regulated and globally alters its chromatin association.
    Stefanelli G; Gandaglia A; Costa M; Cheema MS; Di Marino D; Barbiero I; Kilstrup-Nielsen C; Ausió J; Landsberger N
    Sci Rep; 2016 Jun; 6():28295. PubMed ID: 27323888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MeCP2 regulates gene expression through recognition of H3K27me3.
    Lee W; Kim J; Yun JM; Ohn T; Gong Q
    Nat Commun; 2020 Jun; 11(1):3140. PubMed ID: 32561780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin.
    Nikitina T; Shi X; Ghosh RP; Horowitz-Scherer RA; Hansen JC; Woodcock CL
    Mol Cell Biol; 2007 Feb; 27(3):864-77. PubMed ID: 17101771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin.
    Nan X; Campoy FJ; Bird A
    Cell; 1997 Feb; 88(4):471-81. PubMed ID: 9038338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MeCP2, A Modulator of Neuronal Chromatin Organization Involved in Rett Syndrome.
    Martínez de Paz A; Ausió J
    Adv Exp Med Biol; 2017; 978():3-21. PubMed ID: 28523538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MeCP2: the long trip from a chromatin protein to neurological disorders.
    Ausió J; Martínez de Paz A; Esteller M
    Trends Mol Med; 2014 Sep; 20(9):487-98. PubMed ID: 24766768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MeCP2 nuclear dynamics in live neurons results from low and high affinity chromatin interactions.
    Piccolo FM; Liu Z; Dong P; Hsu CL; Stoyanova EI; Rao A; Tjian R; Heintz N
    Elife; 2019 Dec; 8():. PubMed ID: 31868585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interplay between H2A.Z and H3K9 methylation in regulating HP1α binding to linker histone-containing chromatin.
    Ryan DP; Tremethick DJ
    Nucleic Acids Res; 2018 Oct; 46(18):9353-9366. PubMed ID: 30007360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of linker histone H1, MeCP2, and HMGD1 on nucleosome stability and target site accessibility.
    Riedmann C; Fondufe-Mittendorf YN
    Sci Rep; 2016 Sep; 6():33186. PubMed ID: 27624769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biophysical analysis and small-angle X-ray scattering-derived structures of MeCP2-nucleosome complexes.
    Yang C; van der Woerd MJ; Muthurajan UM; Hansen JC; Luger K
    Nucleic Acids Res; 2011 May; 39(10):4122-35. PubMed ID: 21278419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence features accurately predict genome-wide MeCP2 binding in vivo.
    Rube HT; Lee W; Hejna M; Chen H; Yasui DH; Hess JF; LaSalle JM; Song JS; Gong Q
    Nat Commun; 2016 Mar; 7():11025. PubMed ID: 27008915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MeCP2 is a microsatellite binding protein that protects CA repeats from nucleosome invasion.
    Ibrahim A; Papin C; Mohideen-Abdul K; Le Gras S; Stoll I; Bronner C; Dimitrov S; Klaholz BP; Hamiche A
    Science; 2021 Jun; 372(6549):. PubMed ID: 34324427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatin modification by PSC occurs at one PSC per nucleosome and does not require the acidic patch of histone H2A.
    Lo SM; McElroy KA; Francis NJ
    PLoS One; 2012; 7(10):e47162. PubMed ID: 23071745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.